Sanofi

Drugmakers, Including Pfizer and Sanofi, Set to Raise US Prices on at Least 500 Drugs in January

Drugmakers, Including Pfizer and Sanofi, Set to Raise US Prices on at Least 500 Drugs in January

Several major drug companies, including Pfizer, Sanofi, and Takeda Pharmaceutical, are gearing up to implement price hikes on over 500 drugs in the United States in early January.

Read Full Article

It's Over For Sanofi and Merck European Joint Vaccines Venture

Drug makers Sanofi and Merck & Co. will part ways by the end of the year sealing their partnership for the European vaccines joint venture. Sales has been declining and both companies agreed it is better if they were better off running their own businesses.

Read Full Article

Gates, UK take lead in $7.5 billion pledge for children's vaccines

International donors pledged $7.5 billion on Tuesday to immunize 300 million children in poor countries against deadly diseases such as diarrhea and pneumonia.

Read Full Article

Tax changes weaken case for new Pfizer bid, says AstraZeneca CEO

Recent U.S. tax changes have weakened the case for companies like Pfizer (PFE.N) to shift their tax bases overseas by striking so-called tax inversion deals, according to AstraZeneca's (AZN.L) chief executive.

Read Full Article

Actavis, Sanofi among bidders for Omega Pharma

Generic drugmaker Actavis Plc and France's Sanofi SA are among the suitors for privately held Omega Pharma NV [COUCKO.UL], Bloomberg reported, citing people familiar with the matter.

Read Full Article

Sanofi unveils heart disease partnership with MyoKardia

French drugmaker Sanofi announced on Wednesday a partnership with U.S.-based MyoKardia to develop therapies for patients with genetic heart diseases.

Read Full Article

IBM launches Watson system for research, hopes for breakthroughs

International Business Machines Corp on Wednesday launched a computer system that can quickly identify patterns in massive amounts of data, an ability that IBM said should hasten breakthroughs in science and medical research.

Read Full Article

Sanofi looking growth in Africa through acquisitions

Sanofi is looking to grasp a good hold in Africa through acquisition of business units, according to the firm's CEO Chris Viehbacher who told Reuters.

Read Full Article

Sanofi acquires 12pct in Alnylam Pharmaceuticals and drugs for $700M

Sanofi will be purchasing a 12% stake in Alnylam Pharmaceuticals as well as access to the drugs it has developed for rare diseases, Bloomberg reported.

Read Full Article

Shire to acquire ViroPharma for USD4.2 billion

London-listed drugmaker Shire announced its intention to buy U.S. pharmaceutical company for USD4.2 billion.

Read Full Article

Merck to cut 8,500 jobs

Merck & Co. decided to cut its annual spending by USD2.5 billion and eliminate more than 10% of its global workers.

Read Full Article

ViroPharma to hire Goldman Sachs for possible sale

ViroPharma had attracted interested suitors including Sanofi and Shire Plc. as it started working with Goldman Sachs Group for a possible sale.

Read Full Article

L'Oreal says it has funds for Nestle buy back

French cosmetic firm L'Oreal said it could afford to buy back the EUR 23 billion stake that Nestle holds in the firm.

Read Full Article

First GSK, now China focuses investigations on Sanofi

Xinhua reported that French drugmaker Sanofi had become the focus of bribery investigations by Chinese authorities.

Read Full Article

Sanofi, Novartis and GSK in Race to Acquire Elder Pharma's Domestic Formulations Business

Sanofi, Novartis and GSK are in a race to buy Elder Pharma's formulations unit.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics